Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 3
2014 5
2015 4
2016 3
2017 2
2018 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
What Animal Cancers teach us about Human Biology.
Kattner P, Zeiler K, Herbener VJ, Ferla-Brühl K, Kassubek R, Grunert M, Burster T, Brühl O, Weber AS, Strobel H, Karpel-Massler G, Ott S, Hagedorn A, Tews D, Schulz A, Prasad V, Siegelin MD, Nonnenmacher L, Fischer-Posovszky P, Halatsch ME, Debatin KM, Westhoff MA. Kattner P, et al. Among authors: nonnenmacher l. Theranostics. 2021 May 3;11(14):6682-6702. doi: 10.7150/thno.56623. eCollection 2021. Theranostics. 2021. PMID: 34093847 Free PMC article. Review.
Killing me softly--future challenges in apoptosis research.
Westhoff MA, Brühl O, Nonnenmacher L, Karpel-Massler G, Debatin KM. Westhoff MA, et al. Among authors: nonnenmacher l. Int J Mol Sci. 2014 Mar 3;15(3):3746-67. doi: 10.3390/ijms15033746. Int J Mol Sci. 2014. PMID: 24595238 Free PMC article. Review.
Cell Death Induction in Cancer Therapy - Past, Present, and Future.
Nonnenmacher L, Hasslacher S, Zimmermann J, Karpel-Massler G, La Ferla-Brühl K, Barry SE, Burster T, Siegelin MD, Brühl O, Halatsch ME, Debatin KM, Westhoff MA. Nonnenmacher L, et al. Crit Rev Oncog. 2016;21(3-4):253-267. doi: 10.1615/CritRevOncog.2016016987. Crit Rev Oncog. 2016. PMID: 27915975 Review.
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy.
Westhoff MA, Karpel-Massler G, Brühl O, Enzenmüller S, La Ferla-Brühl K, Siegelin MD, Nonnenmacher L, Debatin KM. Westhoff MA, et al. Among authors: nonnenmacher l. Mol Cell Ther. 2014 Oct 27;2:32. doi: 10.1186/2052-8426-2-32. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056598 Free PMC article. Review.
Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021: a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process.
Papan C, Reifenrath K, Last K, Attarbaschi A, Graf N, Groll AH, Hübner J, Laws HJ, Lehrnbecher T, Liese JG, Martin L, Tenenbaum T, Vieth S, von Both U, Wagenpfeil G, Weichert S, Hufnagel M, Simon A; AB-PPS PedOnc Study Group. Papan C, et al. Lancet Reg Health Eur. 2023 Mar 1;28:100599. doi: 10.1016/j.lanepe.2023.100599. eCollection 2023 May. Lancet Reg Health Eur. 2023. PMID: 37180743 Free PMC article.
RIST: a potent new combination therapy for glioblastoma.
Nonnenmacher L, Westhoff MA, Fulda S, Karpel-Massler G, Halatsch ME, Engelke J, Simmet T, Corbacioglu S, Debatin KM. Nonnenmacher L, et al. Int J Cancer. 2015 Feb 15;136(4):E173-87. doi: 10.1002/ijc.29138. Epub 2014 Sep 1. Int J Cancer. 2015. PMID: 25123598 Free article.
Immune phenotypes predict survival in patients with glioblastoma multiforme.
Mostafa H, Pala A, Högel J, Hlavac M, Dietrich E, Westhoff MA, Nonnenmacher L, Burster T, Georgieff M, Wirtz CR, Schneider EM. Mostafa H, et al. Among authors: nonnenmacher l. J Hematol Oncol. 2016 Sep 1;9(1):77. doi: 10.1186/s13045-016-0272-3. J Hematol Oncol. 2016. PMID: 27585656 Free PMC article.
The effects of PI3K-mediated signalling on glioblastoma cell behaviour.
Langhans J, Schneele L, Trenkler N, von Bandemer H, Nonnenmacher L, Karpel-Massler G, Siegelin MD, Zhou S, Halatsch ME, Debatin KM, Westhoff MA. Langhans J, et al. Among authors: nonnenmacher l. Oncogenesis. 2017 Nov 29;6(11):398. doi: 10.1038/s41389-017-0004-8. Oncogenesis. 2017. PMID: 29184057 Free PMC article.
A paired comparison between glioblastoma "stem cells" and differentiated cells.
Schneider M, Ströbele S, Nonnenmacher L, Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S, Strauss G, Baumann B, Karpel-Massler G, Westhoff MA, Debatin KM, Halatsch ME. Schneider M, et al. Among authors: nonnenmacher l. Int J Cancer. 2016 Apr 1;138(7):1709-18. doi: 10.1002/ijc.29908. Epub 2015 Nov 17. Int J Cancer. 2016. PMID: 26519239 Free article.
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells.
Hasslacher S, Schneele L, Stroh S, Langhans J, Zeiler K, Kattner P, Karpel-Massler G, Siegelin MD, Schneider M, Zhou S, Grunert M, Halatsch ME, Nonnenmacher L, Debatin KM, Westhoff MA. Hasslacher S, et al. Among authors: nonnenmacher l. Int J Oncol. 2018 Nov;53(5):1881-1896. doi: 10.3892/ijo.2018.4528. Epub 2018 Aug 16. Int J Oncol. 2018. PMID: 30132519 Free PMC article.
19 results